Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Bionomics Limited

Clinical trials sponsored by Bionomics Limited, explained in plain language.

Now part of Neuphoria Therapeutics Inc. NEUP NASDAQ

Clinical-stage biotech developing therapies for central nervous system disorders.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

New pill could take the edge off social anxiety on the spot

Symptom relief Completed

This study tested whether a single dose of BNC210 can quickly reduce anxiety in people with social anxiety disorder. 370 adults took either the drug or a placebo before a public speaking challenge and rated their distress. The goal is to see if BNC210 works as an as-needed treatm…

Phase: PHASE3 • Sponsor: Bionomics Limited • Aim: Symptom relief

Last updated Jun 27, 2026 12:35 UTC